Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism

Affiliation

• ¹ Departments of Medicine (S.R., A.M.D., R.E.W.), Pediatrics (S.R., R.E.W.), and Genetics (S.R.), The University of Chicago, Chicago, Illinois 60637; Department of Medicine (J.H.D.B., G.R.W.), Imperial College London, Hammersmith Campus, London W12 0NN, United Kingdom; Department of Clinical Sciences and Community Health (P.B.-P., L.P.), University of Milan, Fondazione Ca' Granda Policlinico (P.B.-P.), and Istituto Auxologico Italiano (L.P.), 20133 Milan, Italy; Instituto de Investigaciones Biomédicas (J.B.), Consejo Superior de Investigaciones Científicas-Universidad Autonoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Raras, 28029 Madrid, Spain; Department of Medicine (G.B.), David Geffen School of Medicine, University of California at Los Angeles, California 90095; Wellcome-Medical Research Council Institute of Metabolic Science (K.C.), University of Cambridge, Cambridge CB2 0QQ, United Kingdom; Thyroidmanager and Endotext (L.J.D.G.), South Dartmouth, Massachusetts 02748; Raymond and Ruth Perelman School of Medicine (J.L.J.), University of Pennsylvania, Philadelphia, Pennsylvania 19104; Division of Endocrinology, Metabolism, and Molecular Medicine and Center for Genetic Medicine (P.A.K.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; Research Institute of Environmental Medicine (Y.M.), Nagoya University, Nagoya 466-8550, Japan; Ecole Normale Supérieure de Lyon (J.S.), 69342 Lyon, France; and Laboratory of Hormone Action, Singapore Institute of Clinical Sciences (P.M.Y.), Singapore 138669.